This Section of Epidemiology and Psychiatric Sciences appears in each issue of the Journal to stress the relevance of epidemiology for behavioral neurosciences, reporting the results of studies that explore the use of an epidemiological approach to provide a better understanding of the neural basis of major psychiatric disorders and, in turn, the utilisation of the behavioural neurosciences for promoting innovative epidemiological research.The ultimate aim is to help the translation of most relevant research findings into every-day clinical practice. These contributions are written in house by the journal's editorial team or commissioned by the Section Editor (no more than 1000 words, short unstructured abstract, 4 key-words, one Generalised anxiety disorder (GAD) is a common psychiatric illness characterised by selective morpho-functional brain alterations. The breath of neuroimaging studies investigating the neural basis of GAD is extensive; however, its pathophysiology is still largely unknown. Specifically for proton Magnetic Resonance Spectroscopy (¹H MRS) investigations, which have the aim of identifying differences in metabolite levels between conditions in key brain areas, often showed contrasting results. Indeed, there are selected ¹H MRS studies reporting deficits of key metabolites in GAD patients; however, collectively the literature remains mixed with respect to consistency of major findings. In this review, we evaluate published ¹H MRS studies on GAD with the final aim of providing a comprehensive overview of the extent of neurometabolic dysfunctions associated with GAD. Interestingly, the majority of the studies reviewed showed altered metabolite levels in the dorsolateral prefrontal cortex and hippocampus suggesting regional specificity. These results also provide evidence of the utility of ¹H MRS not only for elucidating the pathophysiology of neuropsychiatric diseases, but also for the identification of more beneficial and targeted pharmacological interventions. Additionally, future studies are warranted to overcome methodological differences observed across the studies. Key words: Generalised anxiety disorder, magnetic resonance spectroscopy, metabolites, neurochemicals.Generalised anxiety disorder (GAD) is a common psychiatric disease characterised by specific physical and psychological symptoms, including persisting worry, irritability and fatigue (DSM5, American Psychiatry Association, 2013;Diwadkar et al. 2017). GAD causes high human suffering, which is poorly understood.With respect to neuroimaging studies, the exploration of putative biomarkers of this disease is still at an early stage (Terlevic et al. 2012). This is true especially for the application of proton Magnetic Resonance Spectroscopy (¹H MRS), which has the unique ability of providing important quantitative biochemical information in localised brain areas (Stanley, 2002). This can lead to identifying possible and more effective pharmacological treatments for GAD.